STOCK TITAN

BBOT to Participate in Upcoming December Investor Healthcare Conferences

(Neutral)
(Neutral)
Tags

BridgeBio Oncology Therapeutics (Nasdaq: BBOT) said members of its leadership team will present at two investor healthcare conferences in early December 2025.

Presentation schedule: Piper Sandler 37th Annual Healthcare Conference on Tuesday, December 2, 2025 at 2:00 PM ET, and Evercore 8th Annual Healthcare Conference on Wednesday, December 3, 2025 at 9:35 AM ET. Live webcasts will be available on the company's Events page, with replays accessible for at least 90 days after each event.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – BBOT

-5.93%
1 alert
-5.93% Session close to close
$1.01B Market Cap
0.0x Rel. Volume

In the Nov 19 session, BBOT declined 5.93%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

SOUTH SAN FRANCISCO, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced that members of its leadership team will participate in two investor conferences in December.

Details of the company’s participation are as follows:

  • Piper Sandler 37th Annual Healthcare Conference
    Presentation: Tuesday, December 2, at 2:00 p.m. ET
  • 8th Annual Evercore Healthcare Conference
    Presentation: Wednesday, December 3, at 9:35 a.m. ET

Live webcasts of the presentations will be accessible on the “Events” page of the BBOT website at https://investors.bbotx.com/news-events/events. Replays of the webcasts will be available for at least 90 days following the event.

About BBOT
BBOT is a clinical-stage biopharmaceutical company advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3Kα malignancies. BBOT has the goal of improving outcomes for patients with cancers driven by the two most prevalent oncogenes in human tumors. For more information, please visit www.bbotx.com and follow us on LinkedIn.

BBOT Contacts:

Investor Contact:
Heather Armstrong
BBOT
Heather.Armstrong@bbotx.com

Media Contact:
Jake Robison
Inizio Evoke Comms
Jake.robison@inizioevoke.com


FAQ

When will BBOT present at the Piper Sandler 37th Annual Healthcare Conference?

BBOT will present on Tuesday, December 2, 2025 at 2:00 PM ET.

When will BBOT present at the Evercore 8th Annual Healthcare Conference?

BBOT will present on Wednesday, December 3, 2025 at 9:35 AM ET.

Where can investors watch BBOT's December 2025 conference presentations?

Live webcasts and replays will be available on BBOT's Events page at https://investors.bbotx.com/news-events/events.

How long will BBOT conference presentation replays be available?

Replays will be available for at least 90 days following each event.

What topics will BBOT leadership cover at the December 2025 conferences?

The company said leadership will present recent developments and corporate updates; specific agenda details were not provided.